NCT00418080View on ClinicalTrials.gov

Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

December 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

bicalutamide

Trial Locations (1)

67100

University of L'Aquila, L’Aquila

All Listed Sponsors
lead

University of L'Aquila

OTHER

NCT00418080 - Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy | Biotech Hunter | Biotech Hunter